Loading clinical trials...
Loading clinical trials...
A 13-week, Double-blind, Parallel Group, Multi-centre Study to Compare the Bronchial Anti-inflammatory Activity of the Combination of Salmeterol/Fluticasone Propionate 50/500mcg Twice Daily Compared With Placebo Twice Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
Salmeterol/fluticasone propionate 50/500mcg Diskus
Locations
20
Denmark
GSK Investigational Site
Aalborg, Denmark
GSK Investigational Site
København NV, Denmark
GSK Investigational Site
Tallinn, Estonia
GSK Investigational Site
Tartu, Estonia
GSK Investigational Site
Helsinki, Finland
GSK Investigational Site
Palermo, Sicily, Italy
Start Date
October 1, 2002
Completion Date
December 1, 2003
Last Updated
September 15, 2016
NCT06712563
NCT06831994
NCT02755974
NCT05087641
NCT05050591
NCT05913765
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions